| Document Date: 2004-10-14 14:44:53
Open Document File Size: 18,29 KBShare Result on Facebook
MedicalCondition tumor / vomiting / Cancer / disease / colorectal cancer / previously treated nonsmall cell lung cancer / non-small cell lung cancer / diarrhea / neutropenia / nausea / metastatic carcinoma / objective tumor / rectal cancer / metastatic colorectal cancer / severe neutropenia / Sepsis / alopecia / J Cancer / / Organization Clinical Pharmacology Subcommittee / / Product Camptosar / fluorouracil / Irinotecan hydrochloride / / Technology pharmacokinetics / Pharmacogenetics / genotype / UDP / gene expression / /
SocialTag |
Topic 1. Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism Camptosar (Irinotecan hydrochloride injection) received accelerated approval on June 14, 1996 for the treatment of patients with